Hence, it can be inferred that RCC-miR-224-5p cells could be a donor to release EVs containing miR-224-5p and deliver cargoes to recipient cells deferring PD-L1 protein degradation by inhibiting cyclin D1 expression. Here, CD274 is linked to renal cell carcinoma.